68Ga-PSMA PET/CT 在前列腺癌根治性治疗后前列腺特异性抗原升高患者中的检测效能与诊断准确性
前瞻性研究纳入 188 例前列腺癌根治性治疗后随访中 PSA 升高的患者,均行 68Ga-PSMA PET/CT 检查,以组织病理学及临床和影像随访为参考标准。68Ga-PSMA PET/CT 在 165 例中检出肿瘤复发,总体检出率 87.8%(165/188),检测复发的敏感度 98.8%、特异度 100%、准确率 98.8%。作者认为该检查是检测局部复发或前列腺外转移的有价值工具,应纳入常规检查流程。
要点
- PSA 升高(中位 2.2 ng/mL)患者中 68Ga-PSMA PET/CT 总体检出率 87.8%(165/188)。
- 165 例复发中局部复发 35 例、前列腺外转移 106 例、两者合并 24 例。
- 检测复发的敏感度 98.8%、特异度 100%、准确率 98.8%。
核心结论
- 68Ga-PSMA PET/CT 是检测前列腺癌根治性治疗后 PSA 升高患者局部复发或前列腺外转移的有价值工具,应纳入常规检查流程。
研究设计与样本
- 前瞻性研究纳入 188 例前列腺癌根治性治疗后常规随访发现 PSA 升高的患者,均行 68Ga-PSMA PET/CT 检查。
- 以组织病理学及临床和影像随访作为参考标准,判定检测效能与诊断准确性。
- 对每例患者确定疾病分期、Gleason 评分以及局部复发和前列腺外转移的最大标准化摄取值。
关键影像表现/征象
- 68Ga-PSMA PET/CT 在 165 例中检出肿瘤复发,其中局部复发 35 例、前列腺外转移 106 例、合并病灶 24 例。
- 患者 PSA 中位 2.2 ng/mL(范围 0.01–70 ng/mL),总体检出率 87.8%(165/188)。
诊断标准与关键数值
- 68Ga-PSMA PET/CT 检测前列腺癌复发的敏感度 98.8%、特异度 100%、准确率 98.8%,参考标准为组织病理学及临床和影像随访。
临床应用与阅片要点
- 作者认为 68Ga-PSMA PET/CT 应纳入前列腺癌根治性治疗后 PSA 升高患者的常规检查流程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: 68Ga-prostate-specific membrane antigen-11 (68Ga-PSMA-11) is a recently developed positron emission tomography (PET) tracer that can detect prostate cancer (PC) relapses and metastases with high contrast resolution. The aim of this study was to assess the detection efficacy and diagnostic accuracy of 68Ga-PSMA PET/CT image in patients with rising prostatic-specific antigen (PSA) after treatment of PC.
MATERIALS AND METHODS: The present prospective study included 188 patients who exhibited rising of PSA level on a routine follow-up examination after definitive treatment of PC. All patients underwent a 68Ga-PSMA PET/CT examination. For each patient, we determined the disease stage, the Gleason score, and the maximum standardized uptake value of the local recurrence and extraprostatic metastases. The detection efficacy and diagnostic accuracy of 68Ga-PSMA PET/CT were established by histopathology and clinical and imaging follow-up as the reference standards.
RESULTS: 68Ga-PSMA PET/CT detected tumour relapse in 165 patients (35 patients had local recurrence, 106 patients had extraprostatic metastases, and 24 patients had combined lesions). The sensitivity, specificity, and accuracy values of 68Ga-PSMA PET/CT examination in the detection of PC recurrence were 98.8%, 100%, and 98.8%, respectively. 68Ga-PSMA PET/CT revealed an overall detection rate of 87.8% (165/188) in patients with rising PSA (median of 2.2 ng/mL, and range of 0.01-70 ng/mL).
CONCLUSION: 68Ga-PSMA PET/CT is a valuable tool for the detection of PC local recurrence or extraprostatic metastases following rising PSA levels after primary definitive therapy and should be incorporated during routine work-up.
引用
- Hamed MAG, Basha MAA, Ahmed H, et al. 68Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy. Acad Radiol. 2018. PMID: 29935970. doi:10.1016/j.acra.2018.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。